SNCA and Parkinson disease: In the same line, DYRK2 seems to modulate the oligomerization-aggregation of alpha-synuclein, a key hallmark of Parkinson’s Disease (Gonçalves et al., 2016; Gonçalves and Outeiro, 2017).